BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 15336231)

  • 21. Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans.
    Broglio F; Arvat E; Benso A; Gottero C; Muccioli G; Papotti M; van der Lely AJ; Deghenghi R; Ghigo E
    J Clin Endocrinol Metab; 2001 Oct; 86(10):5083-6. PubMed ID: 11600590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of glucose, free fatty acids or arginine load on the GH-releasing activity of ghrelin in humans.
    Broglio F; Benso A; Gottero C; Prodam F; Grottoli S; Tassone F; Maccario M; Casanueva FF; Dieguez C; Deghenghi R; Ghigo E; Arvat E
    Clin Endocrinol (Oxf); 2002 Aug; 57(2):265-71. PubMed ID: 12153607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cortistatin mimics somatostatin by inducing a dual, dose-dependent stimulatory and inhibitory effect on growth hormone secretion in somatotropes.
    Luque RM; Peinado JR; Gracia-Navarro F; Broglio F; Ghigo E; Kineman RD; Malagón MM; Castaño JP
    J Mol Endocrinol; 2006 Jun; 36(3):547-56. PubMed ID: 16720722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GH-related and extra-endocrine actions of GH secretagogues in aging.
    Muller EE; Rigamonti AE; Colonna Vde G; Locatelli V; Berti F; Cella SG
    Neurobiol Aging; 2002; 23(5):907-19. PubMed ID: 12392795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct effect of cortistatin on GH release from cultured pituitary cells in the rat.
    Baranowska B; Chmielowska M; Wolinska-Witort E; Bik W; Baranowska-Bik A; Martynska L
    Neuro Endocrinol Lett; 2006; 27(1-2):153-6. PubMed ID: 16648801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cortistatin-17 and somatostatin-14 display the same effects on growth hormone, prolactin, and insulin secretion in patients with acromegaly or prolactinoma.
    Grottoli S; Gasco V; Broglio F; Baldelli R; Ragazzoni F; Gallenca F; Mainolfi A; Prodam F; Muccioli G; Ghigo E
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1595-9. PubMed ID: 16449338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arginine counteracts the inhibitory effect of recombinant human insulin-like growth factor I on the somatotroph responsiveness to growth hormone-releasing hormone in humans.
    Gianotti L; Maccario M; Lanfranco F; Ramunni J; Di Vito L; Grottoli S; Muller EE; Ghigo E; Arvat E
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3604-8. PubMed ID: 11061509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cortistatin and pituitary hormone secretion in rat.
    Baranowska B; Bik W; Baranowska-Bik A; Wolinska-Witort E; Chmielowska M; Martynska L
    J Physiol Pharmacol; 2009 Mar; 60(1):151-6. PubMed ID: 19439817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of recombinant human insulin-like growth factor I administration on growth hormone (GH) secretion, both spontaneous and stimulated by GH-releasing hormone or hexarelin, a peptidyl GH secretagogue, in humans.
    Ghigo E; Gianotti L; Arvat E; Ramunni J; Valetto MR; Broglio F; Rolla M; Cavagnini F; Müller EE
    J Clin Endocrinol Metab; 1999 Jan; 84(1):285-90. PubMed ID: 9920097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brain-gut communication: cortistatin, somatostatin and ghrelin.
    Broglio F; Papotti M; Muccioli G; Ghigo E
    Trends Endocrinol Metab; 2007 Aug; 18(6):246-51. PubMed ID: 17632010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The endocrine response to ghrelin as a function of gender in humans in young and elderly subjects.
    Broglio F; Benso A; Castiglioni C; Gottero C; Prodam F; Destefanis S; Gauna C; van der Lely AJ; Deghenghi R; Bo M; Arvat E; Ghigo E
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1537-42. PubMed ID: 12679436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth hormone (GH) responses to GH-releasing hormone alone or combined with arginine in patients with adrenal incidentaloma: evidence for enhanced somatostatinergic tone.
    Terzolo M; Bossoni S; Alí A; Doga M; Reimondo G; Milani G; Peretti P; Manelli F; Angeli A; Giustina A
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1310-5. PubMed ID: 10720081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The negative association between total ghrelin levels, body mass and insulin secretion is lost in hypercortisolemic patients with Cushing's disease.
    Giordano R; Picu A; Pagotto U; De Iasio R; Bonelli L; Prodam F; Broglio F; Marafetti L; Pasquali R; Maccario M; Ghigo E; Arvat E
    Eur J Endocrinol; 2005 Oct; 153(4):535-43. PubMed ID: 16189175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Orexin A suppresses in vivo GH secretion.
    Seoane LM; Tovar SA; Perez D; Mallo F; Lopez M; Señaris R; Casanueva FF; Dieguez C
    Eur J Endocrinol; 2004 May; 150(5):731-6. PubMed ID: 15132732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ghrelin does not mediate the somatotroph and corticotroph responses to the stimulatory effect of glucagon or insulin-induced hypoglycaemia in humans.
    Broglio F; Prodam F; Gottero C; Destefanis S; Me E; Riganti F; Giordano R; Picu A; Balbo M; Van der Lely AJ; Ghigo E; Arvat E
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):699-704. PubMed ID: 15163333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased GH secretion and enhanced ACTH and cortisol release after ghrelin administration in Cushing's disease: comparison with GH-releasing peptide-6 (GHRP-6) and GHRH.
    Correa-Silva SR; Nascif SO; Lengyel AM
    Pituitary; 2006; 9(2):101-7. PubMed ID: 16832586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroendocrine and metabolic effects of acute ghrelin administration in human obesity.
    Tassone F; Broglio F; Destefanis S; Rovere S; Benso A; Gottero C; Prodam F; Rossetto R; Gauna C; van der Lely AJ; Ghigo E; Maccario M
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5478-83. PubMed ID: 14602793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stimulatory effects of ghrelin on circulating somatostatin and pancreatic polypeptide levels.
    Arosio M; Ronchi CL; Gebbia C; Cappiello V; Beck-Peccoz P; Peracchi M
    J Clin Endocrinol Metab; 2003 Feb; 88(2):701-4. PubMed ID: 12574202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ghrelin administration affects circulating pituitary and gastro-entero-pancreatic hormones in acromegaly.
    Arosio M; Ronchi CL; Gebbia C; Pizzinelli S; Conte D; Cappiello V; Epaminonda P; Cesana BM; Beck-Peccoz P; Peracchi M
    Eur J Endocrinol; 2004 Jan; 150(1):27-32. PubMed ID: 14713276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prandial regulation of ghrelin secretion in humans: does glucagon contribute to the preprandial increase in circulating ghrelin?
    Soule S; Pemberton C; Hunt P; Cole D; Raudsepp S; Inder W
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):412-7. PubMed ID: 16181233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.